RIM
NVAX icon

Rockbridge Investment Management’s Novavax NVAX Stock Holding History

Rockbridge Investment Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-25
Closed -$4K – 838
2021
Q4 		$4K Hold
25
– – ﹤0.01% 682
2021
Q3 		$5K Buy
+25
New +$5.51K ﹤0.01% 615
2021
Q1 		– Sell
-30
Closed -$3K – 746
2020
Q4 		$3K Buy
+30
New +$3.19K ﹤0.01% 611

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Rockbridge Investment Management's NVAX Position: Q1 2022 in Review

Rockbridge Investment Management sold out of Novavax (NVAX) in Q1 2022, closing a stake of 25 shares — an estimated $4K sold.

Rockbridge Investment Management first reported a position in NVAX in Q4 2020 and held it in 3 quarters. The position peaked at $5K in Q3 2021. 381 funds tracked by Wall St. Rank hold NVAX as of Q1 2022.

  • Rockbridge Investment Management reported no remaining Novavax position as of Q1 2022 after selling out during the quarter.
  • Rockbridge Investment Management sold 25 Novavax shares in Q1 2022, an estimated $4K.
  • Rockbridge Investment Management first reported a position in Novavax in Q4 2020 and held it in 3 quarters.
  • Rockbridge Investment Management's Novavax position peaked at $5K in Q3 2021.
  • 381 funds tracked by Wall St. Rank held Novavax as of Q1 2022.

Based on Rockbridge Investment Management's 13F filing for Q1 2022, filed 28 May 2024.